NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) Short Interest Down 67.6% in January

NLS Pharmaceutics Ltd. (NASDAQ:NLSPW) saw a large decline in short interest during the month of January. As of January 31st, there was short interest totalling 1,200 shares, a decline of 67.6% from the January 15th total of 3,700 shares. Based on an average trading volume of 61,800 shares, the short-interest ratio is currently 0.0 days.

NLS Pharmaceutics Trading Down 7.3 %

Shares of NLS Pharmaceutics stock traded down $0.00 during trading hours on Wednesday, reaching $0.01. 73,570 shares of the company’s stock were exchanged, compared to its average volume of 86,763. NLS Pharmaceutics has a 52-week low of $0.01 and a 52-week high of $0.10. The company has a fifty day moving average of $0.01 and a 200-day moving average of $0.02.

NLS Pharmaceutics Company Profile

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).